Role of astrocyte in neuroinflammation‐induced loss in neuroplasticity and subsequent onset of depression: A systematic review
Neuroprotection · 2025-09 · 3 (3) · 206-225
DOI: 10.1002/nep3.70009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuroprotection, online erschienen am 06.06.2025. Verfasst von Gaurav Singhal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Otolaryngology, Department of Surgery University of Wisconsin Madison Wisconsin USA. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 223 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Depression
Abstract (Originalsprache)
Major depressive disorder (MDD) is a complex psychiatric condition increasingly linked to chronic neuroinflammation, particularly in the context of aging, stress, and systemic comorbidities. While microglia have traditionally been the focus of neuroimmune studies, growing evidence highlights astrocytes as central regulators in the pathogenesis of MDD. This review synthesizes current findings on the multifaceted roles of astrocytes in neuroplasticity, neurotransmission, metabolic support, and blood‐brain barrier regulation. It explores how astrocyte reactivity and the release of pro‐inflammatory cytokines are often triggered by psychosocial stress, aging, and peripheral immune activation and contribute to synaptic dysfunction and cognitive impairment. The review also examines the bidirectional crosstalk between astrocytes and microglia, astrocytic calcium signaling, epigenetic modulation via histone lactylation, and metabolic pathways involving lactate. Special attention is given to the region‐specific and phenotype‐dependent responses of astrocytes, as well as their influence on the onset and maintenance of depressive symptoms. Additionally, therapeutic strategies targeting astrocyte‐mediated pathways, including anti‐inflammatory agents, metabolic modulators, repetitive transcranial magnetic stimulation, and inflammasome inhibitors, are discussed. Finally, methodological challenges and future research directions are outlined, emphasizing the need for precision medicine approaches in developing astrocyte‐targeted interventions for MDD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Otolaryngology, Department of Surgery University of Wisconsin Madison Wisconsin USA.
- Center of Liver-GI Diseases and Transplantation Akash Healthcare Superspeciality Hospital New Delhi New Delhi India.
- Department of Psychiatry University of Münster Münster Germany.
- Department of Psychiatry University of Melbourne Melbourne Victoria Australia.
ORCID-Profile: Gaurav Singhal
Zitieren
APA
Singhal, G., Singhal, S., & Baune, B. T. (2025). Role of astrocyte in neuroinflammation‐induced loss in neuroplasticity and subsequent onset of depression: A systematic review. Neuroprotection, 3(3), 206-225. https://doi.org/10.1002/nep3.70009
Vancouver
Singhal G, Singhal S, Baune BT. Role of astrocyte in neuroinflammation‐induced loss in neuroplasticity and subsequent onset of depression: A systematic review. Neuroprotection. 2025;3(3):206-225. doi:10.1002/nep3.70009
BibTeX
@article{Singhal2025,
author = {Singhal, Gaurav and Singhal, Saurabh and Baune, Bernhard T},
title = {Role of astrocyte in neuroinflammation‐induced loss in neuroplasticity and subsequent onset of depression: A systematic review},
journal = {Neuroprotection},
year = {2025},
volume = {3},
number = {3},
pages = {206--225},
doi = {10.1002/nep3.70009}
}
EUVIMED